Health Affairs November 20, 2025
Judy Butler, Krysten Joyce, Adriane Fugh-Berman

Secretary of Health and Human Services Robert F. Kennedy Jr. wants the United States to limit pharmaceutical ads to consumers, citing concerns that advertising leads to increased use of prescription drugs.

This is a laudable first step to cracking down on pharmaceutical marketing. Certainly, exposing people to ads increases demand for targeted products. One survey found that 1 in 10 adults were prescribed a specific drug after seeing it in an advertisement and asking their doctor about it.

Direct-to-consumer advertising is associated with increased prescription drug use and drug spending, increasing demand for clinically inappropriate, more expensive versions of medications. For example, pharmaceutical companies have spent hundreds of millions of dollars a year promoting newer blood thinners on television, even...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Govt Agencies, HHS, Pharma, Pharma / Biotech
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article